InBodyLtd Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Ki-Chul Cha
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 29.8yrs |
| CEO ownership | 19.9% |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
Recent updates
Be Wary Of InBodyLtd (KOSDAQ:041830) And Its Returns On Capital
Aug 12
InBodyLtd (KOSDAQ:041830) Could Be Struggling To Allocate Capital
Apr 12Why Dividend Hunters Love InBody Co.,Ltd (KOSDAQ:041830)
Mar 25Can InBody Co.,Ltd (KOSDAQ:041830) Performance Keep Up Given Its Mixed Bag Of Fundamentals?
Mar 08Do Insiders Own Lots Of Shares In InBody Co.,Ltd (KOSDAQ:041830)?
Feb 18
How Much Did InBodyLtd's(KOSDAQ:041830) Shareholders Earn From Share Price Movements Over The Last Five Years?
Jan 31Has InBodyLtd (KOSDAQ:041830) Got What It Takes To Become A Multi-Bagger?
Jan 11InBody Co., Ltd. (KOSDAQ:041830) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
Dec 24Why Dividend Hunters Love InBody Co., Ltd. (KOSDAQ:041830)
Dec 17InBody Co., Ltd.'s (KOSDAQ:041830) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Dec 02Do Institutions Own InBody Co., Ltd. (KOSDAQ:041830) Shares?
Nov 17CEO
Ki-Chul Cha (66 yo)
29.8yrs
Tenure
Cha Ki-Chul has been the Chief Executive Officer of InBody Co.,Ltd (formerly known as Biospace Co., Ltd.) since 1995. Dr. Cha served as an Assistant Manager of Daelim R&D Institute. Dr. Cha was a Researche...